About Hyperfine
Hyperfine, Inc. (Nasdaq: HYPR) is a groundbreaking health technology company that has redefined brain imaging with the Swoop system—the first FDA-cleared, portable, ultra-low-field magnetic resonance brain imaging system capable of providing imaging at multiple points of care in healthcare facilities. Founded in 2014 by serial entrepreneur Jonathan Rothberg, PhD, Hyperfine's mission is to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging and data solutions. The Swoop system is an AI-powered portable brain MRI that uses a magnet with a fraction of the field strength (0.064T) used in conventional MRI. This breakthrough enables the device to be brought to the point of care and used safely in almost any care setting without the need for dedicated staff or infrastructure. Simply plugging into a standard outlet, the system is ready to use in minutes and can be operated by any trained healthcare professional. Powered by Optive AI software, the Swoop system brings advanced, AI-driven image reconstruction to ultra-low-field portable MRI, reducing noise and blur with deep learning to enhance image clarity and consistency. The system provides diagnostic-quality imaging across multiple sequences including T1, T2, FLAIR, and DWI in axial, coronal, and sagittal planes. Its open design and quieter operation enhance patient comfort and reduce anxiety, while eliminating exposure to ionizing radiation. Hyperfine serves hospitals (ICU and emergency departments), neurology clinics, and pediatric facilities, making advanced brain imaging accessible where it was previously unavailable. The company partners with charitable foundations including the Gates Foundation and Raising Malawi to deploy portable MRI technology in low- and medium-income countries, addressing critical needs in early brain development monitoring and neurological disease diagnosis in underserved populations.
Mission & Story
Mission
Our mission is to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging, and data solutions.
Founding Story
Hyperfine was founded in 2014 by Jonathan Rothberg, PhD, a serial entrepreneur and the founder or co-founder of numerous innovative companies. With a vision to save lives by making magnetic resonance imaging (MRI) more accessible and affordable, Rothberg and a team of scientists and engineers set out to put MRI within reach of every patient regardless of location. While the Hyperfine team retained the fundamental principles and core components of MRI, they turned nearly everything else on its head, designing the Swoop system for simplicity while leveraging advances in image-centric computing, deep learning, and the ten-million-fold increase in computing power since the invention of MRI technology over 40 years ago. Hyperfine produced the first Swoop system MR brain images within a year of its founding.
Clinical Focus
Medical conditions and clinical areas addressed by Hyperfine.
Who It Serves
Milestones & Awards
Recent Milestones
December 2021: Hyperfine Class A common stock began trading on Nasdaq Global Market under ticker HYPR. Launch of Optive AI software for enhanced image reconstruction. Deployment of systems across multiple international research sites.
Awards & Recognition
First FDA-cleared portable ultra-low-field MRI system
Key Partnerships
Social & Media
Latest Updates
Hyperfine Announces European Launch of Next-Generation Swoop® System
2w ago
Hyperfine Forms Global Neurosurgery Advisory Council to Support Expansion of Portable MRI in Neurosurgical Care
4w ago
Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care
1mo ago
Hyperfine to Join Russell 2000® and Russell 3000® Indexes
1mo ago
Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments
2mo ago
Company Details
- Founded
- 2014
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.